ZDHHC1: A Potential Drug Target Or Biomarker for Multiple Diseases

Target Name: ZDHHC1

NCBI ID: G29800

ZDHHC1

ZDHHC1: A Potential Drug Target Or Biomarker for Multiple Diseases

ZDHHC1 (C16orf1) is a gene that has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZDHHC1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been linked to the development and progression of several diseases.

One of the most promising aspects of ZDHHC1 is its potential as a drug target. The ZDHHC1 gene has been shown to be involved in the regulation of cell growth, differentiation, and survival, and has been linked to the development of cancer. Studies have shown that inhibiting the activity of ZDHHC1 has the potential to be a powerful cancer therapeutic. For example, researchers have found that inhibiting the expression of ZDHHC1 has led to a significant reduction in the growth of cancer cells.

In addition to its potential as a cancer drug target, ZDHHC1 has also been shown to be involved in the regulation of neurodegenerative diseases. The ZDHHC1 gene has been linked to the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, and studies have shown that inhibiting the expression of ZDHHC1 has the potential to be a neurodegenerative disease therapeutic.

ZDHHC1 has also been shown to be involved in the regulation of autoimmune disorders. The ZDHHC1 gene has been linked to the development of autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, and studies have shown that inhibiting the expression of ZDHHC1 has the potential to be an effective autoimmune disorder therapeutic.

In conclusion, ZDHHC1 is a gene that has the potential to be a drug target or biomarker for several diseases. Its role in the regulation of cell growth, differentiation, and survival has been extensively studied, and its potential as a cancer, neurodegenerative disease, and autoimmune disorder therapeutic is being investigated further. Further research is needed to fully understand the role of ZDHHC1 in these diseases and to develop effective therapies for the treatment of these conditions.

Protein Name: Zinc Finger DHHC-type Containing 1

Functions: Palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates (By similarity). Has a palmitoyltransferase activity toward NCDN and regulates NCDN association with endosome membranes through this palmitoylation

The "ZDHHC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZDHHC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets